Ho, C., Lee, F., Huang, S., & Cheng, W. (2018). Everolimus following 5-aza-2-deoxycytidine is a promising therapy in paclitaxel-resistant clear cell carcinoma of the ovary. Am J Cancer Res.
Citação norma ChicagoHo, Chih-Ming, Fa-Kung Lee, Shih-Hung Huang, and Wen-Fang Cheng. "Everolimus Following 5-aza-2-deoxycytidine Is a Promising Therapy in Paclitaxel-resistant Clear Cell Carcinoma of the Ovary." Am J Cancer Res 2018.
Citação norma MLAHo, Chih-Ming, Fa-Kung Lee, Shih-Hung Huang, and Wen-Fang Cheng. "Everolimus Following 5-aza-2-deoxycytidine Is a Promising Therapy in Paclitaxel-resistant Clear Cell Carcinoma of the Ovary." Am J Cancer Res 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.